The cfDNA blood test had 83% sensitivity for CRC, 90% specificity for advanced neoplasia, and 13% sensitivity for advanced precancerous lesions. Other noninvasive screening methods have sensitivity from 67% to 94% for CRC and 22% to 43% for advanced precancerous lesions.
"The results of the study are a promising step toward developing more convenient tools to detect colorectal cancer early while it is more easily treated," said senior author William Grady, MD, medical director of the Gastrointestinal Cancer Prevention Program at the Fred Hutchinson Cancer Center in Seattle, Washington.detection similar to stool tests used for early detection of cancer, could offer an alternative for patients who may otherwise decline current screening options," he sai
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: 10News - 🏆 732. / 50 Read more »
Source: KPRC2 - 🏆 80. / 68 Read more »
Source: wjxt4 - 🏆 246. / 63 Read more »
Source: ksatnews - 🏆 442. / 53 Read more »